Security key
70261F202
Pasithea Therapeutics Corp. - Common Stock, par value $0.0001 per share (KTTA)
CUSIP: 70261F202
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 78,704
- Total 13F value
- $99,102
- Share change
- +1,542
- SEC-reported price per share
- $1.30
- Number of holders
- 7
- Value change
- -$116,583
- Number of buys
- 4
- Number of sells
- 4
- Shares outstanding
- 33,406,228
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
7
Top holders
7
KTTA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2025
Previous quarter: Q4 2024
Pasithea Therapeutics Corp. SEC filings
Pasithea Therapeutics Corp. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 70261F202
Recent filing periods:
Ownership snapshot
Top reported holders of KTTA - Pasithea Therapeutics Corp. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
PD Joint Holdings, LLC Se...
Comparable rows
8/15
Latest evidence
31 Mar 2025
13D/G
13F
3/4/5
Lead comparable stake: 5%
7 rows are not safely comparable across share classes.
13D/G row: ARMISTICE CAPITAL, LLC
Showing 1-6 of 15 holder rows.
Quick read
ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 5%.
8 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 5
ARMISTICE CAPITAL, LLC
5%
Lawrence Steinman
3.1%
UBS Group AG
0.04%
Tower Research Capital LLC (TRC)
0.01%
MORGAN STANLEY
0%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13D/G
13F
Company
|
5%
|
$240,119
142,082 shares
|
+$14,019 | 31 Mar 2025 |
| Lawrence Steinman |
13D/G
|
3.1%
|
$141,720
83,858 shares
|
$0 | 01 Mar 2025 |
| UBS Group AG |
13F
Company
|
0.04%
|
$40,534
12,868 shares
|
— | 31 Dec 2024 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
0.01%
|
$5,941
1,886 shares
|
— | 31 Dec 2024 |
| MORGAN STANLEY |
13F
Company
|
0%
|
$3,150
1,000 shares
|
— | 31 Dec 2024 |
| ROYAL BANK OF CANADA |
13F
Company
|
0%
|
$1,000
250 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
7
Shares
78,704
Rows available
7
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
7
Q1 2025 holders
7
Holder diff
0
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend